Back to calendar
Aprea Therapeutics, Inc. (APRE) Earnings
APRE reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.07
Actual EPS: $-0.07
EPS surprise: 60.56%
Company overview
Market Cap$10.6M
PriceUSD 0.84
EPS (TTM)-1.08
52-week high1.69
52-week low0.55
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees8